Dendrobium refers to medicinal orchid stems used as an herbal supplement for tissue moisture, metabolic balance, and longevity. Oral Dendrobium shows the strongest human evidence for increasing saliva production, protecting mouth tissues, and improving sleep, appetite, bowel regularity, and vitality in older adults. However, oral extract can blunt vaccine antibody production, pre-workout blends carry stimulant and blood pressure risks, and longevity certainty remains modest. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum uric acid | ≤ 420 μmol/L (men); ≤ 360 μmol/L (women) | Expected to change: tracks urate-lowering efficacy of Dendrobium huoshanense |
| Fasting plasma glucose | 3.9–5.5 mmol/L (70–99 mg/dL) | Expected to change: evaluates glycemic response to Dendrobium officinale or Dendrobium nobile |
| Serum triglycerides | < 1.7 mmol/L (< 150 mg/dL) | Expected to change: tracks lipid reduction in metabolic syndrome protocols |
| Resting blood pressure | No established target; change from individual baseline (discontinued if systolic rises > 10 mmHg or exceeds 140/90 mmHg) | Safety check and expected to change: detects pressor spikes from adulterated blends or modest vasodilatory reductions |
| Serum ALT and AST | 7–56 U/L (ALT); 8–33 U/L (AST) (discontinued if > 1.5–2.5× ULN) | Safety check: screens for hepatotoxicity from alkaloid accumulation or dyed/adulterated stems |
| Serum creatinine | 62–106 μmol/L (men); 44–80 μmol/L (women) (discontinued if > 1× ULN) | Safety check: verifies renal clearance stability during supplementation |
Cadence: Baseline panels and seated resting blood pressure prior to supplementation; resting blood pressure before and 1–2 hours post-dose during week 1; metabolic, hepatic, and renal panels repeated at 4 and 12 weeks, then every 3–6 months during cyclic use.